Hirtle Callaghan & Co’s Marvell Technology MRVL Stock Holding History

Hirtle Callaghan & Co’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Buy	+4,113	New	+$825K	0.04%	58

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hirtle Callaghan & Co's MRVL Position: Q2 2026 in Review

Hirtle Callaghan & Co opened a new position in Marvell Technology (MRVL) in Q2 2026: 4,113 shares worth $1.23M. The stake represents 0.04% of the portfolio and ranks #58 among its holdings.

2,207 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Hirtle Callaghan & Co held 4,113 shares of Marvell Technology worth $1.23M as of Q2 2026.
Marvell Technology was a new Hirtle Callaghan & Co position in Q2 2026.
Marvell Technology made up 0.04% of Hirtle Callaghan & Co's portfolio in Q2 2026, its #58 holding.
2,207 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2026, filed 14 Aug 2026.